LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced the first patient has been dosed in its phase 1 clinical trial ...
BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, announced a non-exclusive clinical collaboration with Amgen Inc. (Amgen) to evaluate the combination of BBP-398, a potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results